目的:观察米非司酮配伍米索前列醇终止带器早期妊娠临床效果及安全性。方法:取81例带器妊娠药物流产患者为本次研究对象,设为观察组,取同期100例非带器妊娠行药物流产孕妇为对照组,对照分析两组临床资料。结果:带器早期妊娠者药物流产成功率91.36%,取器成功率100%,阴道出血量少量者占85.16%,未发生中重度生殖道感染。结论:米非司酮配伍米索前列醇终止带器早期妊娠(适时取环),不影响成功率,出血时间、出血量、及妊娠囊排出时间没有增加,不增加感染率,是一种安全、有效的终止早孕方法。 Objective: To observe the clinical efficacy and safety of mifepristone with misoprostol in termination of early pregnancy. Methods: Totally 81 pregnant women with medical abortion patients were selected as the study group. The observation group was taken as the observation group. 100 pregnant women with non-abortion pregnancy undergoing abortion were selected as the control group. The clinical data of two groups were compared. Results: The success rate of medical abortion with early pregnancy was 91.36%, the successful rate was 100%, and the small amount of vaginal bleeding accounted for 85.16%. No severe or moderate genital tract infection occurred. Conclusion: Mifepristone combined with misoprostol termination of early pregnancy device (timely take the ring), does not affect the success rate, bleeding time, blood loss, and gestational sac discharge did not increase, do not increase the infection rate, is a safe Effective termination of early pregnancy methods.